Search results
Market Today: Prothena's Licensing Deal with Bristol Myers and E
Guru Focus· 2 days agoMarket Overview The stock market exhibited mixed action today. There wasn't a lot of conviction from...
5 real-world examples of omnichannel marketing | TechTarget
SearchSecurity.com· 2 days agoMarketers can best accomplish this goal with an omnichannel marketing strategy -- an approach to provide consistent branding and messaging to a desired audience across multiple platforms, including ...
Recursion Pharma Taps Hershberg as Next Chair to Succeed Chavez
Market Watch· 6 days agoRecursion Pharmaceuticals is naming a new chair as Martin Chavez departs after four years at the board's helm. The clinical stage biotechnology company said Friday that it has tapped Dr. Robert ...
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 4% Dividend...
Benzinga· 2 days agoLoading... Loading... During times of turbulence and uncertainty in the markets, even when markets...
Is It Too Late to Buy Vertex Pharmaceuticals Stock?
Motley Fool via Yahoo Finance· 4 days agoVertex Pharmaceuticals (NASDAQ: VRTX) is a fast-growing pharmaceutical company that investors have been bullish on for years. The business generates...
J&J antidepressant eases symptoms, improves sleep in key trial
BioPharma Dive via Yahoo Finance· 1 day agoDive Brief: A new kind of antidepressant eased symptoms and improved sleep among adults enrolled in...
1st-Quarter Earnings Season Results, Expectations for 2024
GuruFocus.com via Yahoo Finance· 21 hours agoFirst-quarter earnings season has become one of the important market supporting factors during...
2 High-Yield Dividend ETFs to Buy to Generate Passive Income | The Motley Fool
The Motley Fool· 3 days agoETFs are very passive investments.
Unlocking Alzheimer’s: Memory Complaints Can Predict Biological Changes in the Brain
SciTechDaily· 18 hours agoA study reveals that reports of memory decline by patients and partners were associated with the...
What's Going On With Mid-Cap Cancer-Focused Verastem Oncology Stock On Friday?
Benzinga via AOL· 6 days agoThursday, Verastem Oncology (NASDAQ:VSTM) announced the initial interim safety and efficacy results...